Testing effectiveness (Phase 2)Study completedNCT02603562
What this trial is testing
Evaluate Safety and Biological Activity of ATYR1940 in Participants With Early Onset Facioscapulohumeral Muscular Dystrophy
Who this might be right for
Facioscapulohumeral Muscular Dystrophy (FSHD)
aTyr Pharma, Inc. 8